1.26
Schlusskurs vom Vortag:
$1.27
Offen:
$1.26
24-Stunden-Volumen:
64,927
Relative Volume:
0.48
Marktkapitalisierung:
$74.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.65M
KGV:
-2.5714
EPS:
-0.49
Netto-Cashflow:
$-24.59M
1W Leistung:
-9.35%
1M Leistung:
-10.00%
6M Leistung:
+9.57%
1J Leistung:
+8.62%
Vivani Medical Inc Stock (VANI) Company Profile
Firmenname
Vivani Medical Inc
Sektor
Branche
Telefon
818-833-5000
Adresse
1350 S. LOOP ROAD, ALAMEDA
Vergleichen Sie VANI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
VANI
Vivani Medical Inc
|
1.26 | 75.24M | 0 | -25.65M | -24.59M | -0.49 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc Aktie (VANI) Neueste Nachrichten
Vivani Medical: Q2 Earnings Snapshot - San Francisco Chronicle
Vivani Medical Secures $10M Through Share Purchase Agreement - TipRanks
Vivani Medical Provides Business Update Including $10M - GlobeNewswire
Novel Semaglutide Implant Shows 20% Weight Loss in Early Study as Vivani Raises Fresh Capital - Stock Titan
Is Vivani Medical Inc. stock entering bullish territoryJuly 2025 Highlights & Verified Short-Term Plans - Newser
How to monitor Vivani Medical Inc. with trend dashboardsJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Using data filters to optimize entry into Vivani Medical Inc.IPO Watch & Safe Capital Preservation Plans - Newser
Is Vivani Medical Inc. impacted by rising ratesBuy Signal & Weekly Top Gainers Trade List - thegnnews.com
How high can Vivani Medical Inc. stock price go in 2025July 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
How Vivani Medical Inc. stock performs during market volatilitySecure Trading Strategy Based on Technical Analysis - Newser
Using flow based indicators on Vivani Medical Inc.Free Capital Protection Trading Strategies - Newser
Measuring Vivani Medical Inc.’s beta against major indicesTrade Setup Builder with Custom Alerts - Newser
What makes Vivani Medical Inc. stock price move sharplyFree Early Entry Picks Before News Breakout - Newser
Applying Elliott Wave Theory to Vivani Medical Inc.Portfolio Review Summary with Five-Year Outlook - Newser
Why Vivani Medical Inc. stock is on top investor watchlistsFree Beginner Friendly Stock Selection Guide - Newser
Vivani Medical Inc.’s volatility index tracking explainedFree Entry Alert With Low Drawdown Strategy - Newser
What’s the recovery path for long term holders of Vivani Medical Inc.Stock Market Watch with Smart Filters - Newser
Analyzing recovery setups for Vivani Medical Inc. investorsWeekly Entry Signal Based Forecast Tool - Newser
Why Vivani Medical Inc. stock attracts strong analyst attentionFree Capital Preserving Trade Plan Templates - Newser
Custom strategy builders for tracking Vivani Medical Inc.Smart Trade Mapping with Entry Details - Newser
Published on: 2025-08-11 03:02:25 - Newser
Is a relief rally coming for Vivani Medical Inc. holdersRisk Aware Trading Ideas with Alert Levels - Newser
Is Vivani Medical Inc. a Top Dividend Stock to Watch in 2025Free Chart Driven High Reward Trading Setup - Newser
Vivani Medical (VANI) Expected to Announce Earnings on Tuesday - Defense World
Vivani Medical VANI 2025Q2 Earnings Preview Downside Risks on Revenue Challenges - AInvest
Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday - MarketBeat
Vivani Medical’s Strategic Advancements and Market Potential Drive Buy Rating - TipRanks
Vivani Medical’s Promising Trial Results and Market Potential Drive Buy Rating - TipRanks
Vivani Medical announces rapid advancement of NPM-139 - MarketScreener
Vivani Medical Announces Positive Phase 1 Study Results - TipRanks
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today - The Globe and Mail
Vivani Medical Announces Rapid Advancement of NPM-139, a - GlobeNewswire
Breakthrough Semaglutide Implant Achieves 20% Weight Loss with Single Dose, Rivals Ozempic Delivery - Stock Titan
Chemours Agrees to $875M Settlement with New Jersey - The Globe and Mail
Vivani Medical Prioritizes Semaglutide-Based Implant with Promising Preclinical Data - AInvest
EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data - Yahoo Finance
Inflation Is Ticking Upwards. Should Tesla Investors Be Worried? - The Globe and Mail
3 Cheap Tech Stocks to Buy Right Now - The Globe and Mail
If You'd Invested $1,000 in Tilray (TLRY) Stock 5 Years Ago, Here's How Much You'd Have Today - The Globe and Mail
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Up 2,726.3% in July - MarketBeat
Chart of the Day 8/4/25: MASSIVE Jobs Revisions Worrying Wall Street - The Globe and Mail
Vivani Medical Inc. Price Holds Above Key Fib LevelChart-Based Trade Entries Gain Analyst Support - metal.it
When is Vivani Medical Inc. stock expected to show significant growthUnlock powerful market trend analysis - Jammu Links News
Should I hold or sell Vivani Medical Inc. stock in 2025Build a portfolio that stands the test of time - Jammu Links News
How does Vivani Medical Inc. compare to its industry peersUnlock powerful trading signals and alerts - Jammu Links News
What catalysts could drive Vivani Medical Inc. stock higher in 2025Capitalize on stocks with high profit margins - Jammu Links News
How many analysts rate Vivani Medical Inc. as a “Buy”Explosive earning power - Jammu Links News
What are the latest earnings results for Vivani Medical Inc.Get expert alerts on market-moving stocks - Jammu Links News
How does Vivani Medical Inc. generate profit in a changing economyHigh-performance stocks for savvy investors - Jammu Links News
Finanzdaten der Vivani Medical Inc-Aktie (VANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):